Search:
   

Friday, April 28, 2017

Data Technical News #2017 - 13
PharmAthene, Inc. (PIP) and Altimmune, Inc. to Merge and Begin Listing on Nasdaq on Friday, May 05, 2017

Markets Impacted:

Products Impacted:

  • All Nasdaq and UTP Data Feeds

Contact Information:

Resources:

What you need to know:

On Friday, May 05, 2017, PharmAthene, Inc. (NYSE MKT: PIP) and Altimmune, Inc. will merge and be listed and begin trading on Nasdaq. PharmAthene, Inc. will have a corporate name and CUSIP change; and will begin trading under the ticker symbol "ALT".

PharmAthene, Inc. will continue to be traded on NYSE MKT through Thursday, May 04, 2017.

Nasdaq requests that market data redistributors retain historical data for PIP.

What are the issue details for the new Nasdaq listing?

The issue mapping for Altimmune, Inc. is as follows:

Issue Name NYSE MKT Ticker through May 04, 2017 Nasdaq Ticker as of May 05, 2017 Nasdaq Market Category Round Lot Size
Altimmune, Inc. PIP
 ALT Nasdaq Global Market 100 shares

What database changes do Nasdaq market data redistributors need to make to accommodate the new listing?

Nasdaq asks that all market data redistributors update their database to reflect the new listing market for Altimmune, Inc. on Friday, May 05, 2017. Nasdaq requests that market data redistributors retain historical data for PIP.

When the issue moves from NYSE MKT to Nasdaq, firms will see a change in the consolidated data source for Altimmune, Inc. Please note that the consolidated market data for all Nasdaq-listed issues is disseminated via the UTP Quotation Data Feed (UQDF) and UTP Trade Data Feed (UTDF). Firms will begin to see quotation and trade data for Altimmune, Inc. on UQDF and UTDF beginning in the pre-market trading hours on Friday, May 05, 2017.

For firms that report end-usage numbers by the query, Nasdaq reminds them that the Level 1, Nasdaq Basic and Nasdaq Last Sale (NLS) counts should include quote and trade queries for Altimmune, Inc. (ALT) beginning on Friday, May 05, 2017.

Contact Information

If you have questions about Altimmune, Inc. please contact:

If you would like to register as a market maker in ALT, please contact:


Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives. To unsubscribe, also click on the enrollment form

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile